LSL Pharma GroupTSXV:LSL +3.28%50 Days Inventory is 117.36 as of Mar. 2026, which is 27% below its 10-year median of 160.16. GuruFocus rates TSXV:LSL with a GF Score™ of 50/100 and a GF Value™ of C$0.72 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 916 Drug Manufacturers companies, LSL Pharma Group ranks better than 51.31% on this metric.
The historical rank and industry rank for LSL Pharma Group's Days Inventory or its related term are showing as below:
TSXV:LSL'
s Days Inventory Range Over the Past 10 Years
Min: 125.16 Med: 160.16 Max: 196.11
Current: 159.81
During the past 6 years, LSL Pharma Group's highest Days Inventory was 196.11. The lowest was 125.16. And the median was 160.16.
TSXV:LSL's Days Inventory is ranked better than 51.31% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs TSXV:LSL: 159.81
LSL Pharma Group's Days Inventory
declined
from Mar. 2025 (210.89) to Mar. 2026 (117.36).
Inventory Turnover measures how fast the company turns over its inventory within a year.
LSL Pharma Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.78.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LSL Pharma Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.21.
LSL Pharma Group (TSXV:LSL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
LSL Pharma Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LSL Pharma Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
LSL Pharma Group Days Inventory Related Terms
LSL Pharma Group Days Inventory Historical Data
* Premium members only.
The historical data trend for LSL Pharma Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LSL Pharma Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where LSL Pharma Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSL Pharma Group (TSXV:LSL) has a Days Inventory of 117.36 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LSL Pharma Group and its competitors. This is 27% below median its historical median of 160.16. Over the past decade, LSL Pharma Group's Days Inventory has ranged from 125.16 to 196.11. According to the industry distribution chart, LSL Pharma Group ranks #446 out of 916 companies in the Drug Manufacturers industry, placing it in the top 48.7%.
Is LSL Pharma Group's Days Inventory too high?
LSL Pharma Group's current Days Inventory of 117.36 is 27% below median its 10-year median of 160.16. Over the past 10 years, this metric has ranged from a low of 125.16 to a high of 196.11. The Drug Manufacturers industry median Days Inventory is 164.43. LSL Pharma Group's value of 117.36 is 28.6% below this industry median. Based on the distribution chart, LSL Pharma Group ranks #446 out of 916 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, LSL Pharma Group has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does LSL Pharma Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, LSL Pharma Group ranks #446 out of 916 companies for Days Inventory. This puts LSL Pharma Group in the upper half of its industry. The industry median Days Inventory is 164.43. LSL Pharma Group's value of 117.36 is 28.6% below this benchmark. Historically, LSL Pharma Group's own Days Inventory has ranged from 125.16 to 196.11 over the past decade. While the company's 10-year median is 160.16 vs. the industry median of 164.43, LSL Pharma Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LSL Pharma Group's current Days Inventory of 117.36 is 28.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LSL Pharma Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LSL Pharma Group's current Days Inventory is 117.36, which is 27% below median its own 10-year median of 160.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LSL Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, LSL Pharma Group (TSXV:LSL) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.72, compared to a current price of C$0.32 — trading 56.3% below its estimated fair value. The current Days Inventory is 117.36, which is 27% below median its 10-year median of 160.16 and 28.6% below the Drug Manufacturers industry median of 164.43. LSL Pharma Group's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For LSL Pharma Group (TSXV:LSL), the current Days Inventory is 117.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LSL Pharma Group (TSXV:LSL) Overvalued in 2026?
Based on GuruFocus' analysis, LSL Pharma Group stock appears to be undervalued.
The current stock price of C$0.32 is trading 56.3% below its estimated GF Value™ of C$0.72.
GuruFocus considers LSL Pharma Group to be Possible Value Trap.
Key valuation signals for TSXV:LSL:
Days Inventory: 117.36 (27% below median its 10-year median of 160.16)
GF Value™: C$0.72 vs. price of C$0.32 (56.3% below fair value)
Industry Position: 28.6% below the Drug Manufacturers median (#446 of 916)
No single metric tells the full story. See the TSXV:LSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LSL Pharma Group Inc develops, manufactures and commercializes sterile pharmaceutical products, cosmetic products and natural health products. It operates in three segments CMO activities include four operating entities LSL Laboratory, Dermolab, Du-Var, and VSI; Integrated Eye-care pharmaceutical company which includes sterile Eye-care manufacturing operation; and Private Label Business includes Juno OTC which commercializes pharmaceutical products with a focus on private label, over the counter (OTC) products. It derives majority of revenue from CMO activities segment.
50GF Score
Get the complete analysis for TSXV:LSL
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:LSL has been successfully added to your 
